Emcure Share Price Target – Emcure Pharmaceuticals Limited, a prominent pharmaceutical enterprise situated in Pune, is dedicated to the research, development, production, and international distribution of an extensive assortment of pharmaceutical products spanning multiple therapeutic domains. According to the MAT September 2023 data, the company ranked fourth in terms of market share within its designated markets and 13th among pharmaceutical companies in India in terms of domestic sales. Emcure Pharmaceuticals manufactures a broad range of pharmaceutical and biopharmaceutical products, including pills, liquids, injections, and complicated compounds, from its 13 manufacturing locations in India.
What Is Emcure Pharma?
Emcure Pharmaceuticals Limited was founded in 1981 and is a pharmaceutical product manufacturer and marketer. The R&D product portfolio of the company include injectables, biotherapeutics, and orals. The corporation operates in 70 countries worldwide, with a notable emphasis on Europe, Canada, and India. It is present in the majority of the main therapeutic categories, such as cardiovascular, gynecological, HIV antivirals, blood-related, oncology/anti-neoplastics, vitamins, minerals, and nutrients.
Within the therapeutic areas of HIV antivirals and gynecology, it is the largest, fourth-largest, and fourteenth-largest company in India. ii) based on domestic sales for MAT in FY2024 divided by market share in our covered markets, and iii) based on domestic sales for MAT in FY2024.
Overview of Emcure Pharma Share Price
- MARKET CAP – ₹ 23,512.49 Cr.
- Open: ₹1,263.00
- High – Low: ₹1,269.70 – ₹1,226.60
- Previous Close: ₹1,236.70
- Total Traded Value: 2,79,561
- 52 Weeks High: ₹1,408.70 (Jul 15, 2024)
- 52 Weeks Low: ₹1,231.65 (Aug 05, 2024)
Emcure Pharma Share Price Target 2024 to 2030
| YEAR | SHARE PRICE TARGET |
| 2024 | ₹1402 |
| 2025 | ₹1500 |
| 2026 | ₹1600 |
| 2027 | ₹1715 |
| 2028 | ₹1802 |
| 2029 | ₹1900 |
| 2030 | ₹2000 |
How to purchase Emcure Pharma Share Price
You can purchase Emcure Pharma shares through a number of buying and selling platforms, including Groww, Angel One, Upstox, Zerodha, and Groww.
Peer Companies of Emcure Pharma
In the field of Pharmacy, Emcure has competition from a number of notable companies, including:
- Dr Reddy’s Laboratories Limited
- Cipla Limited
- Alkem Laboratories Limited
- Torrent Pharmaceuticals Limited
- Mankind Pharma Limited
- Abbott India Limited
Investor Type & Ratios for Emcure Pharma Share
| Promoter | 78.1% |
| FII | 1.8% |
| DII | 3.4% |
| Public | 16.8% |
| Others | 0.0% |
Advantages & Disadvantages for Emcure Pharma Share Price
Advantages:
- The business is positioned favorably in the home market.
- It has illustrated the Brand Building Capabilities.
- Its product portfolio is large, diverse, and expanding quickly in international markets.
- The business also has strong manufacturing and research and development capabilities.
Disadvantages:
- The business must comply with a number of laws in India and other countries.
- High working capital requirements. 3. In the past, it has disclosed negative cash flows.
- In India, a larger share of total revenue comes from restricted therapeutic areas.
- The corporation faces complicated management, legal, tax, and economic risks as a result of its foreign operations.
FAQs More About Emcure Share Price
Is Emcure good for long term?
Emcure is also in a good position to grow steadily over the long run.
What is the rank of Emcure in India?
Driven by the ‘Shark Tank’ star Namita Thapar’s family, Emcure Pharma has the 13th position in the Indian pharmaceutical sector.
Who are Emcure competitors?
Prominent industry participants including Dr. Reddy’s Laboratories Ltd., Cipla, Alkem Laboratories, Torrent Pharmaceuticals, Mankind Pharma, Abbott India Ltd., and JB Chemicals & Pharmaceuticals are among the company’s main rivals in India.
